Generic placeholder image

Current Hypertension Reviews

Editor-in-Chief

ISSN (Print): 1573-4021
ISSN (Online): 1875-6506

Review Article

Treatment of Hypertension in Children

In Press, (this is not the final "Version of Record"). Available online 24 July, 2024
Author(s): Francesca Mainieri*, Veronica Maria Tagi and Francesco Chiarelli
Published on: 24 July, 2024

DOI: 10.2174/0115734021305332240712103602

Price: $95

Abstract

Hypertension is a real problem in children. It shows a tracking behaviour, representing a key risk factor for hypertension, cardiovascular disease, and end-organ failure in adulthood. However, the importance of addressing arterial hypertension in children is not limited to its risk of tracking into adulthood. Thus, early detection and management are crucial. Hypertension may be primary or due to secondary causes, and identification of this distinction is very important for the treatment setting. Importantly, the management of hypertension in children is crucial to prevent the well-known cardiovascular effects in adulthood. As demonstrated in the literature, healthy eating habits, together with regular physical activity, can have a major impact on reducing high blood pressure and preventing organ damage in children and adolescents. However, suppose these are not sufficient to treat hypertension. In that case, if patients are symptomatic and/or have additional metabolic conditions such as obesity, type diabetes mellitus, or chronic kidney disease, anti-hypertensive medication must be started. Recent guidelines have provided clear guidance on the treatment of hypertension and hypertensive crisis in pediatric age. On the other hand, there are currently few specific recommendations on the treatment of isolated nocturnal hypertension and treatment-resistant hypertension. This review aims to summarize the most recent recommendations for the treatment of hypertension and hypertensive crisis in children and the last years' knowledge and experience in treating childhood isolated nocturnal hypertension and resistant hypertension of childhood.

[1]
de Ferranti, S.D.; Steinberger, J.; Ameduri, R.; Baker, A.; Gooding, H.; Kelly, A.S.; Mietus-Snyder, M.; Mitsnefes, M.M.; Peterson, A.L.; St-Pierre, J.; Urbina, E.M.; Zachariah, J.P.; Zaidi, A.N. Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the american heart association. Circulation, 2019, 139(13), e603-e634.
[http://dx.doi.org/10.1161/CIR.0000000000000618] [PMID: 30798614]
[2]
Urbina, E.M.; Khoury, P.R.; Bazzano, L.; Burns, T.L.; Daniels, S.; Dwyer, T.; Hu, T.; Jacobs, D.R., Jr; Juonala, M.; Prineas, R.; Raitakari, O.; Steinberger, J.; Venn, A.; Woo, J.G.; Sinaiko, A. Relation of blood pressure in childhood to self-reported hypertension in adulthood. Hypertension, 2019, 73(6), 1224-1230.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12334] [PMID: 31067199]
[3]
McNiece, KL; Poffenbarger, TS; Turner, JL; Franco, KD; Sorof, JM; Portman, RJ Prevalence of hypertension and pre-hypertension among adolescents. J. Pediatr., 2007, 150(6), 640-644.
[4]
Symonides, B.; Jędrusik, P.; Artyszuk, Ł.; Gryboś, A.; Dziliński, P.; Gaciong, Z. Different diagnostic criteria significantly affect the rates of hypertension in 18-year-old high school students. Arch. Med. Sci., 2010, 5(5), 689-694.
[http://dx.doi.org/10.5114/aoms.2010.17082] [PMID: 22419926]
[5]
Yang, Y.; Min, J.; Chang, L.; Chai, J.; Song, Z.; Zha, S.; Zhang, M.; Liu, H.; Yang, F. Prevalence trends of hypertension among 9–17 aged children and adolescents in Yunnan, 2017–2019: A serial cross-sectional surveillance survey. BMC Public Health, 2021, 21(1), 338.
[http://dx.doi.org/10.1186/s12889-021-10258-1] [PMID: 33579239]
[6]
Yaru, P.T.; Aliu, R.; Uniga, J.A.; Bashir, I. Gender variation in the prevalence of childhood hypertension. West Afr. J. Med., 2023, 40(11)(Suppl. 1), S6.
[PMID: 37970784]
[7]
Song, P.; Zhang, Y.; Yu, J.; Zha, M.; Zhu, Y.; Rahimi, K.; Rudan, I. Global prevalence of hypertension in children. JAMA Pediatr., 2019, 173(12), 1154-1163.
[http://dx.doi.org/10.1001/jamapediatrics.2019.3310] [PMID: 31589252]
[8]
Couch, S.C.; Saelens, B.E.; Khoury, P.R.; Dart, K.B.; Hinn, K.; Mitsnefes, M.M.; Daniels, S.R.; Urbina, E.M. Dietary approaches to stop hypertension dietary intervention improves blood pressure and vascular health in youth with elevated blood pressure. Hypertension, 2021, 77(1), 241-251.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.120.16156] [PMID: 33190559]
[9]
Farhangi, M.A.; Fathi Azar, E.; Manzouri, A.; Rashnoo, F.; Shakarami, A. Prolonged screen watching behavior is associated with high blood pressure among children and adolescents: A systematic review and dose–response meta-analysis. J. Health Popul. Nutr., 2023, 42(1), 89.
[http://dx.doi.org/10.1186/s41043-023-00437-8] [PMID: 37653414]
[10]
Lurbe, E.; Agabiti-Rosei, E.; Cruickshank, J.K.; Dominiczak, A.; Erdine, S.; Hirth, A.; Invitti, C.; Litwin, M.; Mancia, G.; Pall, D.; Rascher, W.; Redon, J.; Schaefer, F.; Seeman, T.; Sinha, M.; Stabouli, S.; Webb, N.J.; Wühl, E.; Zanchetti, A. 2016 european society of hypertension guidelines for the management of high blood pressure in children and adolescents. J. Hypertens., 2016, 34(10), 1887-1920.
[http://dx.doi.org/10.1097/HJH.0000000000001039] [PMID: 27467768]
[11]
Flynn, J.T.; Kaelber, D.C.; Baker-Smith, C.M.; Blowey, D.; Carroll, A.E.; Daniels, S.R.; de Ferranti, S.D.; Dionne, J.M.; Falkner, B.; Flinn, S.K.; Gidding, S.S.; Goodwin, C.; Leu, M.G.; Powers, M.E.; Rea, C.; Samuels, J.; Simasek, M.; Thaker, V.V.; Urbina, E.M. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics, 2017, 140(3), e20171904.
[http://dx.doi.org/10.1542/peds.2017-1904] [PMID: 28827377]
[12]
Eddolls, W.T.B.; McNarry, M.A.; Stratton, G.; Winn, C.O.N.; Mackintosh, K.A. High-intensity interval training interventions in children and adolescents: A systematic review. Sports Med., 2017, 47(11), 2363-2374.
[http://dx.doi.org/10.1007/s40279-017-0753-8] [PMID: 28643209]
[13]
Ketelhut, S.; Kircher, E.; Ketelhut, S.R.; Wehlan, E.; Ketelhut, K. Effectiveness of multi-activity, high-intensity interval training in school-aged children. Int. J. Sports Med., 2020, 41(4), 227-232.
[http://dx.doi.org/10.1055/a-1068-9331] [PMID: 31935779]
[14]
Son, W.M.; Sung, K.D.; Bharath, L.P.; Choi, K.J.; Park, S.Y. Combined exercise training reduces blood pressure, arterial stiffness, and insulin resistance in obese prehypertensive adolescent girls. Clin. Exp. Hypertens., 2017, 39(6), 546-552.
[http://dx.doi.org/10.1080/10641963.2017.1288742] [PMID: 28590143]
[15]
Seo, Y.G.; Lim, H.; Kim, Y.; Ju, Y.S.; Lee, H.J.; Jang, H.B.; Park, S.I.; Park, K.H. The effect of a multidisciplinary lifestyle intervention on obesity status, body composition, physical fitness, and cardiometabolic risk markers in children and adolescents with obesity. Nutrients, 2019, 11(1), 137.
[http://dx.doi.org/10.3390/nu11010137] [PMID: 30634657]
[16]
Hagman, E.; Danielsson, P.; Elimam, A.; Marcus, C. The effect of weight loss and weight gain on blood pressure in children and adolescents with obesity. Int. J. Obes., 2019, 43(10), 1988-1994.
[http://dx.doi.org/10.1038/s41366-019-0384-2] [PMID: 31152153]
[17]
Burrello, J.; Erhardt, E.M.; Saint-Hilary, G.; Veglio, F.; Rabbia, F.; Mulatero, P.; Monticone, S.; D’Ascenzo, F. Pharmacological treatment of arterial hypertension in children and adolescents. Hypertension, 2018, 72(2), 306-313.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.10862] [PMID: 29967035]
[18]
Bullo, M.; Tschumi, S.; Bucher, B.S.; Bianchetti, M.G.; Simonetti, G.D. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: A systematic review. Hypertension, 2012, 60(2), 444-450.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.112.196352] [PMID: 22753220]
[19]
Samuel, J.P.; Tyson, J.E.; Green, C.; Bell, C.S.; Pedroza, C.; Molony, D.; Samuels, J. Treating hypertension in children with n -of-1 trials. Pediatrics, 2019, 143(4), e20181818.
[http://dx.doi.org/10.1542/peds.2018-1818] [PMID: 30842257]
[20]
Hamdani, G.; Flynn, J.T.; Becker, R.C.; Daniels, S.R.; Falkner, B.; Hanevold, C.D.; Ingelfinger, J.R.; Lande, M.B.; Martin, L.J.; Meyers, K.E.; Mitsnefes, M.; Rosner, B.; Samuels, J.A.; Urbina, E.M. Prediction of ambulatory hypertension based on clinic blood pressure percentile in adolescents. Hypertension, 2018, 72(4), 955-961.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.11530] [PMID: 30354718]
[21]
Hardy, S.T.; Urbina, E.M. Blood pressure in childhood and adolescence. Am. J. Hypertens., 2021, 34(3), 242-249.
[http://dx.doi.org/10.1093/ajh/hpab004] [PMID: 33821942]
[22]
Seeman, T.; Hamdani, G.; Mitsnefes, M. Hypertensive crisis in children and adolescents. Pediatr. Nephrol., 2019, 34(12), 2523-2537.
[http://dx.doi.org/10.1007/s00467-018-4092-2] [PMID: 30276533]
[23]
Baracco, R. A practical guide to the management of severe hypertension in children. Paediatr. Drugs, 2020, 22(1), 13-20.
[http://dx.doi.org/10.1007/s40272-019-00377-z] [PMID: 31919683]
[24]
Lee, G.H.; Lee, I.R.; Park, S.J.; Kim, J.H.; Oh, J.Y.; Shin, J.I. Hypertensive crisis in children: An experience in a single tertiary care center in Korea. Clin. Hypertens., 2016, 22(1), 10.
[http://dx.doi.org/10.1186/s40885-016-0040-2] [PMID: 27092268]
[25]
Arce, C.; Segura-Pacheco, B.; Perez-Cardenas, E.; Taja-Chayeb, L.; Candelaria, M.; Dueñnas-Gonzalez, A. Hydralazine target: From blood vessels to the epigenome. J. Transl. Med., 2006, 4(1), 10.
[http://dx.doi.org/10.1186/1479-5876-4-10] [PMID: 16507100]
[26]
Flynn, J.T.; Bradford, M.C.; Harvey, E.M. Intravenous hydralazine in hospitalized children and adolescents with hypertension. J. Pediatr., 2016, 168, 88-92.
[http://dx.doi.org/10.1016/j.jpeds.2015.07.070] [PMID: 26340877]
[27]
Ostrye, J.; Hailpern, S.M.; Jones, J.; Egan, B.; Chessman, K.; Shatat, I.F. The efficacy and safety of intravenous hydralazine for the treatment of hypertension in the hospitalized child. Pediatr. Nephrol., 2014, 29(8), 1403-1409.
[http://dx.doi.org/10.1007/s00467-014-2772-0] [PMID: 24554119]
[28]
Thomas, C.A.; Moffett, B.S.; Wagner, J.L.; Mott, A.R.; Feig, D.I. Safety and efficacy of intravenous labetalol for hypertensive crisis in infants and small children. Pediatr. Crit. Care Med., 2011, 12(1), 28-32.
[http://dx.doi.org/10.1097/PCC.0b013e3181e328d8] [PMID: 20495503]
[29]
Flynn, J.T.; Tullus, K. Severe hypertension in children and adolescents: Pathophysiology and treatment. Pediatr. Nephrol., 2009, 24(6), 1101-1112.
[http://dx.doi.org/10.1007/s00467-008-1000-1] [PMID: 18839219]
[30]
Tenney, F.; Sakarcan, A. Nicardipine is a safe and effective agent in pediatric hypertensive emergencies. Am. J. Kidney Dis., 2000, 35(5), e20.1-, e20.3.
[http://dx.doi.org/10.1016/S0272-6386(00)70285-X] [PMID: 10793049]
[31]
Flynn, J.T.; Mottes, T.A.; Brophy, P.D.; Kershaw, D.B.; Smoyer, W.E.; Bunchman, T.E. Intravenous nicardipine for treatment of severe hypertension in children. J. Pediatr., 2001, 139(1), 38-43.
[http://dx.doi.org/10.1067/mpd.2001.114030] [PMID: 11445792]
[32]
Drover, D.R.; Hammer, G.B.; Barrett, J.S.; Cohane, C.A.; Reece, T.; Zajicek, A.; Schulman, S.R. Evaluation of sodium nitroprusside for controlled hypotension in children during surgery. Front. Pharmacol., 2015, 6, 136.
[http://dx.doi.org/10.3389/fphar.2015.00136] [PMID: 26217225]
[33]
Moffett, B.S.; Price, J.F. Evaluation of sodium nitroprusside toxicity in pediatric cardiac surgical patients. Ann. Pharmacother., 2008, 42(11), 1600-1604.
[http://dx.doi.org/10.1345/aph.1L192] [PMID: 18957627]
[34]
Blaszak, R.T.; Savage, J.A.; Ellis, E.N. The use of short-acting nifedipine in pediatric patients with hypertension. J. Pediatr., 2001, 139(1), 34-37.
[http://dx.doi.org/10.1067/mpd.2001.114699] [PMID: 11445791]
[35]
Stein, D.R.; Ferguson, M.A. Evaluation and treatment of hypertensive crises in children. Integr. Blood Press. Control, 2016, 9, 49-58.
[PMID: 27051314]
[36]
Miyashita, Y.; Peterson, D.; Rees, J.M.; Flynn, J.T. Isradipine for treatment of acute hypertension in hospitalized children and adolescents. J. Clin. Hypertens., 2010, 12(11), 850-855.
[http://dx.doi.org/10.1111/j.1751-7176.2010.00347.x] [PMID: 21054771]
[37]
Halling, S.E.; Åsling-Monemi, K.; Herthelius, M.; Celsi, G.; Vavilis, G.; Kuru, N.K.; Efvergren, M.; Krmar, R.T. Minoxidil therapy in children and young adult patients with renal disease and refractory hypertension: Value when multidrug regimens have failed to achieve blood pressure control. J. Hum. Hypertens., 2010, 24(8), 552-554.
[http://dx.doi.org/10.1038/jhh.2010.40] [PMID: 20410918]
[38]
Guzman-Limon, M.L.; Jiang, S.; Ng, D.; Flynn, J.T.; Warady, B.; Furth, S.L.; Samuels, J.A. Nocturnal hypertension in children with chronic kidney disease is common and associated with progression to kidney replacement therapy. Hypertension, 2022, 79(10), 2288-2297.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.18101] [PMID: 35979846]
[39]
Li, Y.; Wang, J.G. Isolated nocturnal hypertension: A disease masked in the dark. Hypertension, 2013, 61(2), 278-283.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.00217] [PMID: 23248146]
[40]
Syrseloudis, D.; Tsioufis, C.; Andrikou, I.; Mazaraki, A.; Thomopoulos, C.; Mihas, C.; Papaioannou, T.; Tatsis, I.; Tsiamis, E.; Stefanadis, C. Association of nighttime hypertension with central arterial stiffness and urinary albumin excretion in dipper hypertensive subjects. Hypertens. Res., 2011, 34(1), 120-125.
[http://dx.doi.org/10.1038/hr.2010.192] [PMID: 20962782]
[41]
O’Flynn, A.M.; Madden, J.M.; Russell, A.J.; Curtin, R.J.; Kearney, P.M. Isolated nocturnal hypertension and subclinical target organ damage: A systematic review of the literature. Hypertens. Res., 2015, 38(8), 570-575.
[http://dx.doi.org/10.1038/hr.2015.43] [PMID: 25832917]
[42]
Awazu, M. Isolated nocturnal hypertension in children. Front Pediatr., 2022, 10, 823414.
[http://dx.doi.org/10.3389/fped.2022.823414] [PMID: 35252065]
[43]
Lee, S.H.; Kim, J.H.; Kang, M.J.; Lee, Y.A.; Won Yang, S.; Shin, C.H. Implications of nocturnal hypertension in children and adolescents with type 1 diabetes. Diabetes Care, 2011, 34(10), 2180-2185.
[http://dx.doi.org/10.2337/dc11-0830] [PMID: 21911774]
[44]
Pais, P.; Dello Strologo, L.; Iyengar, A.; Velusamy, V.; Greenbaum, L.A. Nocturnal hypertension and left ventricular hypertrophy in pediatric renal transplant recipients in South India. Pediatr. Transplant., 2020, 24(4), e13710.
[http://dx.doi.org/10.1111/petr.13710] [PMID: 32320120]
[45]
Strumph, K.; Hafeman, M.; Ranabothu, S.; Gomes, W.; Benitez, S.; Kaskel, F.; Manwani, D.; Mahgerefteh, J. Nocturnal hypertension associated with stroke and silent cerebral infarcts in children with sickle cell disease. Pediatr. Blood Cancer, 2021, 68(5), e28883.
[http://dx.doi.org/10.1002/pbc.28883] [PMID: 33405393]
[46]
Seeman, T.; Hradský, O.; Gilík, J. Isolated nocturnal hypertension is associated with increased left ventricular mass index in children. Pediatr. Nephrol., 2021, 36(6), 1543-1550.
[http://dx.doi.org/10.1007/s00467-020-04861-4] [PMID: 33411072]
[47]
Fujita, H.; Matsuoka, S.; Awazu, M. Masked isolated nocturnal hypertension in children and young adults. Pediatr. Cardiol., 2018, 39(1), 66-70.
[http://dx.doi.org/10.1007/s00246-017-1728-0] [PMID: 28948314]
[48]
Düzova, A.; Karabay Bayazit, A.; Canpolat, N.; Niemirska, A.; Kaplan Bulut, I.; Azukaitis, K.; Karagoz, T.; Oguz, B.; Erdem, S.; Anarat, A.; Ranchin, B.; Shroff, R.; Djukic, M.; Harambat, J.; Yilmaz, A.; Yildiz, N.; Ozcakar, B.; Büscher, A.; Lugani, F.; Wygoda, S.; Tschumi, S.; Zaloszyc, A.; Jankauskiene, A.; Laube, G.; Galiano, M.; Kirchner, M.; Querfeld, U.; Melk, A.; Schaefer, F.; Wühl, E. Isolated nocturnal and isolated daytime hypertension associate with altered cardiovascular morphology and function in children with chronic kidney disease. J. Hypertens., 2019, 37(11), 2247-2255.
[http://dx.doi.org/10.1097/HJH.0000000000002160] [PMID: 31205198]
[49]
Seeman, T.; Pfaff, M.; Sethna, C.B. Isolated nocturnal hypertension in pediatric kidney transplant recipients. Pediatr. Transplant., 2022, 26(2), e14192.
[http://dx.doi.org/10.1111/petr.14192] [PMID: 34845793]
[50]
Höcker, B.; Weber, L.T.; John, U.; Drube, J.; Fehrenbach, H.; Klaus, G.; Pohl, M.; Seeman, T.; Fichtner, A.; Wühl, E.; Tönshoff, B. Steroid withdrawal improves blood pressure control and nocturnal dipping in pediatric renal transplant recipients: Analysis of a prospective, randomized, controlled trial. Pediatr. Nephrol., 2019, 34(2), 341-348.
[http://dx.doi.org/10.1007/s00467-018-4069-1] [PMID: 30178240]
[51]
McGlothan, K.R.; Wyatt, R.J.; Ault, B.H.; Hastings, M.C.; Rogers, T.; DiSessa, T.; Jones, D.P. Predominance of nocturnal hypertension in pediatric renal allograft recipients. Pediatr. Transplant., 2006, 10(5), 558-564.
[http://dx.doi.org/10.1111/j.1399-3046.2006.00521.x] [PMID: 16856991]
[52]
Šuláková, T.; Janda, J. Ambulatory blood pressure in children with diabetes 1. Pediatr. Nephrol., 2008, 23(12), 2285-2286.
[http://dx.doi.org/10.1007/s00467-008-0905-z] [PMID: 18607642]
[53]
Macumber, I.R.; Weiss, N.S.; Halbach, S.M.; Hanevold, C.D.; Flynn, J.T. The association of pediatric obesity with nocturnal non-dipping on 24-hour ambulatory blood pressure monitoring. Am. J. Hypertens., 2016, 29(5), 647-652.
[http://dx.doi.org/10.1093/ajh/hpv147] [PMID: 26310663]
[54]
Bayrakci, U.S.; Schaefer, F.; Duzova, A.; Yigit, S.; Bakkaloglu, A. Abnormal circadian blood pressure regulation in children born preterm. J. Pediatr., 2007, 151(4), 399-403.
[http://dx.doi.org/10.1016/j.jpeds.2007.04.003] [PMID: 17889077]
[55]
Massella, L.; Mekahli, D.; Paripović, D.; Prikhodina, L.; Godefroid, N.; Niemirska, A.; Ağbaş, A.; Kalicka, K.; Jankauskiene, A.; Mizerska-Wasiak, M.; Afonso, A.C.; Salomon, R.; Deschênes, G.; Ariceta, G.; Özçakar, Z.B.; Teixeira, A.; Duzova, A.; Harambat, J.; Seeman, T.; Hrčková, G.; Lungu, A.C.; Papizh, S.; Peco-Antic, A.; De Rechter, S.; Giordano, U.; Kirchner, M.; Lutz, T.; Schaefer, F.; Devuyst, O.; Wühl, E.; Emma, F. Prevalence of hypertension in children with early-stage ADPKD. Clin. J. Am. Soc. Nephrol., 2018, 13(6), 874-883.
[http://dx.doi.org/10.2215/CJN.11401017] [PMID: 29674338]
[56]
Uzu, T.; Ishikawa, K.; Fujii, T.; Nakamura, S.; Inenaga, T.; Kimura, G. Sodium restriction shifts circadian rhythm of blood pressure from nondipper to dipper in essential hypertension. Circulation, 1997, 96(6), 1859-1862.
[http://dx.doi.org/10.1161/01.CIR.96.6.1859] [PMID: 9323073]
[57]
Kario, K.; Tomitani, N.; Kanegae, H.; Ishii, H.; Uchiyama, K.; Yamagiwa, K.; Shiraiwa, T.; Katsuya, T.; Yoshida, T.; Kanda, K.; Hasegawa, S.; Hoshide, S. Comparative effects of an angiotensin II receptor blocker (ARB)/Diuretic vs. ARB/Calcium-Channel blocker combination on uncontrolled nocturnal hypertension evaluated by information and communication technology-based nocturnal home blood pressure monitoring. The NOCTURNE study. Circ. J., 2017, 81(7), 948-957.
[http://dx.doi.org/10.1253/circj.CJ-17-0109] [PMID: 28321001]
[58]
Hermida, R.C.; Ayala, D.E.; Mojón, A.; Fernández, J.R. Influence of circadian time of hypertension treatment on cardiovascular risk: Results of the MAPEC study. Chronobiol. Int., 2010, 27(8), 1629-1651.
[http://dx.doi.org/10.3109/07420528.2010.510230] [PMID: 20854139]
[59]
Stojanovic, M.; Deljanin-Ilic, M.; Ilic, S.; Ilic, B. Isolated nocturnal hypertension: An unsolved problem—when to start treatment and how low should we go? J. Hum. Hypertens., 2020, 34(10), 739-740.
[http://dx.doi.org/10.1038/s41371-020-00403-5] [PMID: 32814807]
[60]
Macumber, I.; Flynn, J.T. Does treatment-resistant hypertension exist in children? A review of the evidence. Pediatr. Nephrol., 2020, 35(6), 969-976.
[http://dx.doi.org/10.1007/s00467-019-04268-w] [PMID: 31147776]
[61]
Stanley, J.C.; Criado, E.; Upchurch, G.R., Jr; Brophy, P.D.; Cho, K.J.; Rectenwald, J.E.; Kershaw, D.B.; Williams, D.M.; Berguer, R.; Henke, P.K.; Wakefield, T.W. Pediatric renovascular hypertension: 132 primary and 30 secondary operations in 97 children. J. Vasc. Surg., 2006, 44(6), 1219-1228.
[http://dx.doi.org/10.1016/j.jvs.2006.08.009] [PMID: 17055693]
[62]
O’Neill, J.A., Jr Long-term outcome with surgical treatment of renovascular hypertension. J. Pediatr. Surg., 1998, 33(1), 106-111.
[http://dx.doi.org/10.1016/S0022-3468(98)90373-6] [PMID: 9473112]
[63]
Kimura, H.; Sato, O.; Deguchi, J.O.; Miyata, T. Surgical treatment and long-term outcome of renovascular hypertension in children and adolescents. Eur. J. Vasc. Endovasc. Surg., 2010, 39(6), 731-737.
[http://dx.doi.org/10.1016/j.ejvs.2010.03.019] [PMID: 20430657]
[64]
Redhead, E.C.G.; Paessler, A.; Arslan, Z.; Patel, P.; Minhas, K.; Forman, C.; Hollis, P.; Lava, S.; Ionescu, F.; Manuel, D.; Ray, S.; Kessaris, N.; Giardini, A.; Ratnamma, V.; Dobby, N.; Tullus, K.; Simmonds, J.; Stojanovic, J. Cardiovascular outcomes improve in children with renovascular hypertension following endovascular and surgical interventions. Pediatr. Nephrol., 2024, 39(2), 521-530.
[http://dx.doi.org/10.1007/s00467-023-06123-5] [PMID: 37658875]
[65]
Hinz, L.; Pacaud, D.; Kline, G. Congenital adrenal hyperplasia causing hypertension: An illustrative review. J. Hum. Hypertens., 2018, 32(2), 150-157.
[http://dx.doi.org/10.1038/s41371-017-0002-5] [PMID: 29255217]
[66]
Bonanni, A.; Pasetti, F.; Ghiggeri, G.M.; Gandolfo, C. Renal denervation for severe hypertension in a small child with Turner syndrome: Miniaturisation of the procedure and results. BMJ Case Rep., 2015, 2015, bcr2014208777.
[http://dx.doi.org/10.1136/bcr-2014-208777] [PMID: 25759273]
[67]
Carey, R.M.; Calhoun, D.A.; Bakris, G.L.; Brook, R.D.; Daugherty, S.L.; Dennison-Himmelfarb, C.R.; Egan, B.M.; Flack, J.M.; Gidding, S.S.; Judd, E.; Lackland, D.T.; Laffer, C.L.; Newton-Cheh, C.; Smith, S.M.; Taler, S.J.; Textor, S.C.; Turan, T.N.; White, W.B. Resistant hypertension: Detection, evaluation, and management: A scientific statement from the american heart association. Hypertension, 2018, 72(5), e53-e90.
[http://dx.doi.org/10.1161/HYP.0000000000000084] [PMID: 30354828]
[68]
Buchhorn, R.; Ziemer, G.; Jetter, H.M.M.; M Borst, M.; Selbach, J. Renal sympathetic denervation for resistant hypertension in a child after aortic coarctation surgery. Int. J. Cardiol., 2014, 172(3), e447-e448.
[http://dx.doi.org/10.1016/j.ijcard.2013.12.317] [PMID: 24491868]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy